Your Location:Home > Products > Pharma & Intermediates > Pharmaceutical intermediate >20744-39-2
Product Details
InChI:InChI=1/C4H5N3/c5-4-1-2-6-7-3-4/h1-3H,(H2,5,6)
The invention relates to the technical f...
The present invention discloses novel co...
There is provided a FAAH inhibitor and a...
Compounds of Formula (IA), IB), IC), and...
3,6-dichloropyridazin-4-amine
4-aminopyridazine
Conditions | Yield |
---|---|
With
sodium hydroxide; hydrogen;
palladium 10% on activated carbon;
In
tetrahydrofuran; water;
at 20 ℃;
for 48h;
|
100% |
With
5%-palladium/activated carbon; hydrogen; sodium hydroxide;
In
ethanol;
at 25 ℃;
Reagent/catalyst;
Inert atmosphere;
Large scale;
|
94.7% |
With
sodium hydroxide; palladium on activated charcoal;
Hydrogenation;
|
|
With
sodium hydroxide; palladium on activated charcoal;
Hydrogenation;
|
3,4,5-trichloropyridazine
4-aminopyridazine
Conditions | Yield |
---|---|
With
sodium hydroxide;
palladium;
In
ethanol; ethyl acetate;
|
|
With
sodium hydroxide;
palladium on charcoal;
In
ethanol; ethyl acetate;
|
|
3,4,5-trichloropyridazine;
With
ammonia;
In
ethanol;
at 0 - 20 ℃;
for 96h;
With
hydrogen; sodium hydroxide;
palladium on carbon;
In
ethanol;
|
3,6-dichloropyridazin-4-amine
5-amino-3,4-dichloropyridazine
(3,5-dichloropyridazin-4-yl)amine
1,2-diazine
9-tert-butylfluorene
tert-butyl N-(4-pyridazinyl)carbamate
3-aminopyridazine
phenyl N-(pyridazin-4-yl)carbamate
CAS:74150-27-9
CAS:88477-37-6
CAS:65202-58-6